Jessica Pollard, MD^1,2, Todd A. Alonzo, PhD^3,4, Robert B. Gerbing, MA^4*, Susana C. Raimondi, PhD⁵, Betsy A. Hirsch, PhD^6*, Lillian Sung, MD, PhD⁷, Richard Aplenc, MD, PhD⁸, Erin M. Guest, MD⁹, Irwin D. Bernstein, MD^10,11, Michael R. Loken, PhD^12*, Soheil Meshinchi, MD, PhD^10,13 and Alan S. Gamis, MD, MPH¹⁴

¹Maine Children's Cancer Program, Maine Medical Center, Scarborough, ME
²Department of Pediatrics, Tufts University, Boston, MA
³Keck School of Medicine, University of Southern California, Los Angeles, CA
⁴Children's Oncology Group, Monrovia, CA
⁵Department of Pathology, St. Jude Children's Research Hospital, Memphis, TN
⁶University of Minnesota, Minneapolis, MN
⁷Population Health Sciences, Research Institute, Division of Hematology/Oncology, Department of Pediatrics, The Hospital for Sick Children, Toronto, ON, Canada
⁸Division of Oncology, Children's Hospital of Philadelphia, Philadelphia, PA
⁹Division of Hematology/Oncology, Children's Mercy Hospitals & Clinics, Kansas City, MO
¹⁰Department of Pediatrics, University of Washington, Seattle
¹¹Fred Hutchinson Cancer Research Center, Seattle, WA
¹²Hematologics Inc., Seattle, WA
¹³Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA
¹⁴Division of Hematology/Oncology/Bone Marrow Transplantation, Children's Mercy Hospitals and Clinics, Kansas City, MO

Jessica Pollard, MD^1,2, Todd A. Alonzo, PhD^3,4, Robert B. Gerbing, MA^4*, Yi-Cheng Wang, MS^4*, Jason Joaquin^5*, Susana C. Raimondi, PhD⁶, Betsy A. Hirsch, PhD^7*, Lillian Sung, MD, PhD⁸, Richard Aplenc, MD, PhD⁹, Irwin D. Bernstein, MD^5,10, Alan S. Gamis, MD, MPH¹¹ and Soheil Meshinchi, MD, PhD^10,12

¹Maine Children's Cancer Program, Maine Medical Center, Scarborough, ME
²Department of Pediatrics, Tufts University, Boston, MA
³Keck School of Medicine, University of Southern California, Los Angeles, CA
⁴Children's Oncology Group, Monrovia, CA
⁵Fred Hutchinson Cancer Research Center, Seattle, WA
⁶Department of Pathology, St. Jude Children's Research Hospital, Memphis, TN
⁷University of Minnesota, Minneapolis, MN
⁸Population Health Sciences, Research Institute, Division of Hematology/Oncology, Department of Pediatrics, The Hospital for Sick Children, Toronto, ON, Canada
⁹Division of Oncology, Children's Hospital of Philadelphia, Philadelphia, PA
¹⁰Department of Pediatrics, University of Washington, Seattle
¹¹Division of Hematology/Oncology/Bone Marrow Transplantation, Children's Mercy Hospitals and Clinics, Kansas City, MO
¹²Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA

Annette Fasan, PhD^1*, Claudia Haferlach, MD¹, Karolína Perglerová^2*, Sonja Schindela^1*, Susanne Schnittger, PhD¹, Wolfgang Kern, MD¹ and Torsten Haferlach¹

¹MLL Munich Leukemia Laboratory, Munich, Germany
²MLL2 s.r.o., Praha, Czech Republic

Vincent-Philippe Lavallée, M.D.^1,2, Patrick Gendron, M.Sc^1*, Geneviève Boucher, M.Sc^1*, Sébastien Lemieux, Ph.D.^1*, Richard Neil Armstrong, Ph.D.^1*, Isabel Boivin, M.Sc^1*, Guy Sauvageau, M.D., Ph.D.^1,2,3,4 and Josée Hébert, M.D.^1,2,3,4

¹The Leucegene project at Institute for Research in Immunology and Cancer, Université de Montréal, Montréal, QC, Canada
²Hematology-Oncology Division, Maisonneuve-Rosemont Hospital, Montréal, QC, Canada
³Department of Medicine, Faculty of Medicine, Université de Montréal, Montréal, QC, Canada
⁴Quebec Leukemia Cell Bank, Maisonneuve-Rosemont Hospital, Montréal, QC, Canada

Elli Papaemmanuil, PhD^1*, Moritz Gerstung, PhD^1*, Lars Bullinger, MD², Verena I. Gaidzik, MD^2*, Peter Paschka, MD², Michael Heuser, M.D.³, Felicitas Thol, MD⁴, Niccolo Bolli, MD⁵, Arnold Ganser, M.D.⁴, Konstanze Dohner, MD⁶, Richard F. Schlenk, MD⁷, Hartmut Dohner, MD² and Peter J Campbell, MD, PhD^5*

¹Wellcome Trust Sanger Institute, Cambridge, United Kingdom
²Department of Internal Medicine III, University Hospital of Ulm, Ulm, Germany
³Hematology, Hemostasis, Oncology and SCT, Hannover Medical School, Hannover, Germany
⁴Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany
⁵Cancer genome Project, Wellcome Trust Sanger Institute, Cambridge, United Kingdom
⁶Department of Internal Medicine III,, University of Ulm, Ulm, Germany
⁷University Hospital of Ulm, Ulm, Germany

Patricia Silva^1*, Martin Neumann, MD^1,2*, Sebastian Vosberg, MSc^3,4,5*, Cornelia Schlee^1*, Konstandina Isaakidis^1*, Michael P Schroeder^1*, Jutta Ortiz-Tánchez^1*, Lars R. Fransecky^1*, Teresa Hartung^1*, Alexander Graf, PhD^4*, Stefan Krebs, PhD^4*, Helmut Blum, PhD^4*, Gerhard Ehninger^6,7, Hubert Serve, MD^8,9, Wolfgang E Berdel, MD¹⁰, Philipp A. Greif^11,12,13*, Christoph Röllig, MD^6,14* and Claudia D Baldus, MD^1,2

¹Department of Hematology and Oncology, Charité University Hospital, Berlin, Germany
²German Cancer Consortium (DKTK), Berlin, Germany
³Department of Internal Medicine III, Ludwig-Maximilians-University, Munich, Germany
⁴Laboratory for Functional Genome Analysis, Gene-Center, Ludwig-Maximilians-University, Munich, Germany
⁵German Cancer Consortium (DKTK), Heidelberg, Germany
⁶German Cancer Consortium (DKTK), Dresden, Germany
⁷Medical Clinic and Polyclinic I, University Hospital TU Dresden, Dresden, Germany
⁸German Cancer Consortium, Frankfurt, Germany
⁹Department for Hematology/Oncology, Goethe-University Hospital Frankfurt, Frankfurt am Main, Germany
¹⁰Department of Medicine A, University Hospital Münster, Muenster, Germany
¹¹German Cancer Consortium (DKTK), Munich, Germany
¹²Department of Internal Medicine 3, Ludwig-Maximilians-University, Munich, Germany
¹³German Cancer Research Center (DKFZ), Heidelberg, Germany
¹⁴Department of Medicine I, University Hospital Carl Gustav Carus, Dresden, Germany